Literature DB >> 25220806

Molecular insights into dimerization inhibition of c-Maf transcription factor.

Sara Pellegrino1, Luca Ronda2, Chiara Annoni1, Alessandro Contini1, Emanuela Erba1, Maria Luisa Gelmi1, Riccardo Piano2, Gianluca Paredi3, Andrea Mozzarelli4, Stefano Bettati5.   

Abstract

The Maf protein family belongs to the activator protein 1 (AP-1) superfamily of transcription factors that bind specific DNA target sequences through a basic region and exploit a leucine zipper (LZ) motif for protein-protein interactions leading to homo- or hetero-dimerization. Mafs unique DNA-binding domain contains a highly conserved extended homology region (EHR) that allows to recognize longer DNA sequences than other basic leucine zipper (bZIP) transcription factors. Inspired by the fact that overexpression of Mafs is observed in about 50% of cases of multiple myeloma, a hematological malignant disorder, we undertook a peptide inhibitor approach. The LZ domain of c-Maf, one of large Mafs, was produced by solid phase peptide synthesis. We characterized its secondary structure and dimerization properties, and found that dimerization and folding events are strictly coupled. Moreover, potential peptidic c-Maf dimerization inhibitors were computationally designed and synthesized. These compounds were demonstrated by circular dichroism (CD) spectroscopy and MALDI-TOF mass spectrometry to bind to c-Maf LZ monomers, to drive folding of their partially disordered structure and to efficiently compete with dimerization, suggesting a way for interfering with the function of c-Maf and, more generally, of intrinsically disordered proteins, till now considered undruggable targets.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dimerization inhibitor; Intrinsically disordered protein; Maf transcription factor; Molecular dynamics; Multiple myeloma; Solid phase peptide synthesis

Year:  2014        PMID: 25220806     DOI: 10.1016/j.bbapap.2014.09.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Examining How the MAFB Transcription Factor Affects Islet β-Cell Function Postnatally.

Authors:  Holly A Cyphert; Emily M Walker; Yan Hang; Sangeeta Dhawan; Rachana Haliyur; Lauren Bonatakis; Dana Avrahami; Marcela Brissova; Klaus H Kaestner; Anil Bhushan; Alvin C Powers; Roland Stein
Journal:  Diabetes       Date:  2018-11-13       Impact factor: 9.461

Review 2.  Directly targeting transcriptional dysregulation in cancer.

Authors:  Thomas J Gonda; Robert G Ramsay
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

Review 3.  c-MAF, a Swiss Army Knife for Tolerance in Lymphocytes.

Authors:  Claire Imbratta; Hind Hussein; Fabienne Andris; Grégory Verdeil
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

Review 4.  The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology.

Authors:  Fengjuan Fan; Klaus Podar
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.